Lymphoma and Male Fertility

“I was diagnosed with cancer when I was 24. I was told treatments might make me sterile. Even though I was single, I banked my sperm. I am now the proud father of twin boys.” Michael, cancer survivor



The last thing most people expect is a cancer diagnosis. From the minute it occurs, all you want to do is get on with your life. If you still want to father children, then sperm banking may be an option.



If you are a newly diagnosed patient with a short time period to bank sperm, consider ordering the Live:On kit by calling (800) 466-2796. The cost to order a kit is $65. When the kit is returned to Cryogenic Laboratories, Inc. (CLI), you will be billed $560 for processing, analysis, freezing, and one year of storage*. The total cost is $625. Monthly storage plans and discount longer term storage plans are also available for your selection.



Spermbankdirectory.com is a national directory of sperm cryobanks that also offers information on sperm banking.
www.spermbankdirectory.com

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap